Practical Approaches to Reducing the Cost Burden Associated
With Diabetes-Related Care

References: Introduction

1. Freid VM, Prager K, MacKay AP, Xia H. Chartbook on trends in the health of Americans. US Department of Health and Human Services. Health, United States 2003. Hyattsville, Md: National Center for Health Statistics; 2003:17-85.


2. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.


3. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA. 1996;276:1409-1415.


4. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.


5. Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care. 1997;20:735-744.

Return to CME Introduction